SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-15-000297
Filing Date
2015-05-18
Accepted
2015-05-18 17:05:59
Documents
1
Group Members
C. RICHARD KRAMLICHDAVID M. MOTTFOREST BASKETTHARRY R. WELLERKRISHNA S. KOLLURIMICHAEL JAMES BARRETTNEA 13 GP LTDNEA PARTNERS 13 L.P.PATRICK J. KERINSPETER J. BARRISRAVI VISWANATHANRYAN D. DRANTSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 CLOVIS clovis-sch13d_17811.htm SC 13D/A 107677
  Complete submission text file 0001072613-15-000297.txt   109556
Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 410-244-0115
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by) CIK: 0001452907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A

Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86488 | Film No.: 15873990
SIC: 2834 Pharmaceutical Preparations